Advanced Search
LU Sheng, WU Wei, HOU Dongsheng, ZHU Xiaocheng, YAO Libin, HONG Jian, SHAO Yong. Comparison of effectiveness and nutritional condition in obese T2DM rats after sleeve gastrectomy-transit bipartition and biliopancreatic diversion with duodenal switch[J]. Journal of Xuzhou Medical University, 2022, 42(7): 478-483. DOI: 10.3969/j.issn.2096-3882.2022.07.002
Citation: LU Sheng, WU Wei, HOU Dongsheng, ZHU Xiaocheng, YAO Libin, HONG Jian, SHAO Yong. Comparison of effectiveness and nutritional condition in obese T2DM rats after sleeve gastrectomy-transit bipartition and biliopancreatic diversion with duodenal switch[J]. Journal of Xuzhou Medical University, 2022, 42(7): 478-483. DOI: 10.3969/j.issn.2096-3882.2022.07.002

Comparison of effectiveness and nutritional condition in obese T2DM rats after sleeve gastrectomy-transit bipartition and biliopancreatic diversion with duodenal switch

More Information
  • Received Date: March 23, 2021
  • Revised Date: June 05, 2022
  • Objective To compare the weight loss, hypoglycemic effect and nutritional condition of type 2 diabetes mellitus(T2DM) rats with obesity after sleeve gastrectomy-transit bipartition (SG-TB) and biliopancreatic diversion with duodenal switch (BPD-DS). Methods T2DM diabetes rats with obesity were induced through intraperitoneal injection of a low-dose streptozotocin (35 mg/kg) using high-fat diet for one month. Twenty-four successfully modeled rats were randomly divided into three groups (n=8): a SG-TB group, a BPD-DS group and a sham operation (SHAM) group. Before operation and at post-operative 1 to 3 months, their food intake and body weight were measured; the fasting blood glucose (FBG) were measured; and oral glucose tolerance test (OGTT) and insulin resistance test (ITT) were performed. Before operation and post-operative 1 and 3 months, glucagon-like peptide (GLP-1) and insulin were detected; homeostasis model assessment of insulin resistance (HOMA-IR) was calculated; and the contents of serum albumin (ALB), calcium (Ca), ferrum (Fe), and vitamin B12 (VB12) were detected. Results ①There was no statistical difference in each indicators among the SG-TB group, the BPD-DS group and the SHAM group before operation (P>0.05). ②One to three months after surgery, the body weight and food intake of the SG-TB and BPD-DS groups were remarkably lower than those before surgery, and lower than those of the SHAM group at the corresponding time points (P<0.05). Compared with the BPD-DS group, the SG-TB group showed increases in body weight at post-operative 1-3 months, and increases in food intake one month after operation (P<0.05). ③Both the SG-TB and BPD-DS groups showed significantly lower FBG, OGTT AUC and ITT AUC than the SHAM group (P<0.05). But no statistical difference was found between the SG-TB and BPD-DS groups (P>0.05). ④Compared with the SHAM group, remarkable increases in GLP-1 AUC were found in the BPD-DS group one month after operation and in the SG-TB group at post-operative 3 months (P<0.05). The SG-TB group showed lower GLP-1 AUC than the BPD-DS group, without statistical difference (P>0.05). Both the SG-TB and BPD-DS groups showed significantly lower Insulin AUC and HOMA-IR than the SHAM group (P<0.05). The insulin AUC of the SG-TB group was higher than that of BPD-DS groups at post-operative 1 month (P<0.05). ⑤Both the SG-TB and BPD-DS groups showed significantly lower Fe content than the SHAM group at post-operative 1 and 3 months (P<0.05), but no statistical difference was found between the SG-TB and BPD-DS groups (P>0.05). Compared with the SHAM group, the BPD-DS group showed deceases in Ca content at post-operative 1 and 3 month (P<0.05), while the SG-TB group showed deceases in Ca content three months after operation (P<0.05). The SG-TB group presented lower ALB than the SHAM group one month after operation, while the BPD-DS group presented lower ALB than the SB-TB and SHAM groups at post-operative 1 and 3 month (P<0.05). After operation, both the SG-TB and BPD-DS groups showed lower VB12 content than the SHAM group, without statistical differences (P>0.05). Conclusions SG-TB is easy to operate and has similar effect in improving blood glucose as BPD-DS, with a slightly lower risk of malnutrition than BPD-DS.
  • [1]
    Piché ME, Tchernof A, Després JP.Obesity phenotypes, diabetes, and cardiovascular diseases[J].Circ Res, 2020, 126(11):1477-1500.
    [2]
    Seravalle G, Grassi G.Obesity and hypertension[J].Pharmacol Res, 2017, 122:1-7.
    [3]
    Kolotkin RL, Meter K, Williams GR.Quality of life and obesity[J].Obes Rev, 2001, 2(4):219-229.
    [4]
    李梦伊, 刘洋, 赵象文, 等.大华北减重与代谢手术临床资料数据库2019年度报告[J].中国实用外科杂志, 2020, 40(4):418-425.
    [5]
    Yu J, Zhou X, Li L, et al.The long-term effects of bariatric surgery for type 2 diabetes:systematic review and meta-analysis of randomized and non-randomized evidence[J].Obes Surg, 2015, 25(1):143-158.
    [6]
    Strain GW, Torghabeh MH, Gagner M, et al.The impact of biliopancreatic diversion with duodenal switch (BPD/DS) over 9 years[J].Obes Surg, 2017, 27(3):787-794.
    [7]
    Sorribas M, Casajoana A, Sobrino L, et al.Experience in biliopancreatic diversion with duodenal switch:Results at 2, 5 and 10 years[J].Cir Esp (Engl Ed), 2022, 100(4):202-208.
    [8]
    Topart PA, Becouarn G.Revision and reversal after biliopancreatic diversion for excessive side effects or ineffective weight loss:a review of the current literature on indications and procedures[J].Surg Obes Relat Dis, 2015, 11(4):965-972.
    [9]
    Alalwan AA, Friedman J, Park H, et al.US national trends in bariatric surgery:A decade of study[J].Surgery, 2021, 170(1):13-17.
    [10]
    AI M, Taskin HE.Sleeve gastrectomy with transit bipartition in a series of 883 patients with mild obesity:early effectiveness and safety outcomes[J].Surg Endosc, 2022, 36(4):2631-2642.
    [11]
    Liu P, Widjaja J, Dolo PR, et al.Comparing the anti-diabetic effect of sleeve gastrectomy with transit bipartition against sleeve gastrectomy and Roux-en-Y gastric bypass using a diabetic rodent model[J].Obesity surgery, 2021, 31(5):2203-2210.
    [12]
    Biertho L, Simon-Hould F, Marceau S, et al.Current outcomes of laparoscopic duodenal switch[J/OL].Ann Surg Innov Res, 2016, 10:1.
    [13]
    Risstad H, Søvik TT, Engström M, et al.Five-year outcomes after laparoscopic gastric bypass and laparoscopic duodenal switch in patients with body mass index of 50 to 60:a randomized clinical trial[J].JAMA surgery, 2015, 150(4):352-361.
    [14]
    Biertho L, Lebel S, Marceau S, et al.Biliopancreatic diversion with duodenal switch:surgical technique and perioperative care[J].Surg Clin North Am, 2016, 96(4):815-826.
    [15]
    Mingrone G, Castagneto-Gissey L.Mechanisms of early improvement/resolution of type 2 diabetes after bariatric surgery[J].Diabetes Metab, 2009, 35(6 Pt 2):518-523.
    [16]
    Sandoval D.CNS GLP-1 regulation of peripheral glucose homeostasis [J].Physiol Behav, 2008, 94(5):670-674.
    [17]
    Buteau J.GLP-1 receptor signaling:effects on pancreatic beta-cell proliferation and survival [J].Diabetes Metab, 2008, Suppl 2:S73-S77.
    [18]
    Topart P, Becouarn G, Finel JB.Comparison of 2-year results of Roux-en-Y gastric bypass and transit bipartition with sleeve gastrectomy for superobesity[J].Obes Surg, 2020, 30(9):3402-3407.

Catalog

    Article views (819) PDF downloads (1737) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return